Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Gap Down – Here’s Why

Ono Pharmaceutical Co. (OTCMKTS:OPHLF) shares gapped down before the market opened on Monday . The stock had previously closed at $14.94, but opened at $14.15. Ono Pharmaceutical shares last traded at $14.15, with a volume of 200 shares changing hands.

Analyst Ratings Changes

Separately, Zacks Research lowered Ono Pharmaceutical from a “strong-buy” rating to a “hold” rating in a research report on Friday, September 4th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock presently has an average rating of “Hold”.

Ono Pharmaceutical Stock Performance

The company’s 50-day moving average price is $14.89 and its 200 day moving average price is $14.60. The stock has a market capitalization of $6.65 billion, a PE ratio of 13.48 and a beta of 0.33. The company has a debt-to-equity ratio of 0.08, a quick ratio of 2.86 and a current ratio of 3.28.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd. is a Japanese research-driven pharmaceutical company headquartered in Osaka. The company discovers, develops, manufactures and markets prescription medicines, with a focus on oncology, immunology, neurology and other specialty-care areas. Its activities include both internally developed products and collaborations with pharmaceutical and biotechnology companies worldwide.

Ono is best known internationally for Opdivo (nivolumab), an immune checkpoint inhibitor developed in collaboration with Bristol Myers Squibb and used to treat multiple types of cancer.